scholarly journals MO01.32 CodeBreaK 200: A Phase 3 Multicenter Study of Sotorasib, a KRAS(G12C) Inhibitor, versus Docetaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Harboring KRAS p.G12C Mutation

2021 ◽  
Vol 16 (1) ◽  
pp. S29
Author(s):  
M. Reck ◽  
A. Spira ◽  
B. Besse ◽  
J. Wolf ◽  
F. Skoulidis ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Multicenter Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 3 ◽  
Previously Treated

scholarly journals Phase 3 trial comparing nab-paclitaxel with docetaxel for previously treated advanced non–small cell lung cancer

2021 ◽  
Author(s):  
Yasuto Yoneshima ◽  
Satoshi Morita ◽  
Masahiko Ando ◽  
Atsushi Nakamura ◽  
Shunichiro Iwasawa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 3 ◽  
Previously Treated

scholarly journals Atezolizumab in Japanese Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study

2018 ◽  
Vol 19 (4) ◽  
pp. e405-e415 ◽  
Author(s):  
Toyoaki Hida ◽  
Reiko Kaji ◽  
Miyako Satouchi ◽  
Norihiko Ikeda ◽  
Atsushi Horiike ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Subgroup Analysis ◽  
Japanese Patients ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 3 ◽  
Previously Treated
Sign in / Sign up

Export Citation Format

Share Document